NuCana plc Operating Expenses 2011-2026 | NCNA

Annual Operating Expenses NuCana plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	25.7 M	22 M	24 M	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
25.7 M	22 M	23.9 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
MannKind Corporation MNKD	88 M	$ 3.56	24.48 %	$ 1.09 B	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Bio-Techne Corporation TECH	688 M	$ 47.41	-16.36 %	$ 7.47 B	USA
United Therapeutics Corporation UTHR	1.52 B	$ 596.76	4.29 %	$ 26.4 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BioNTech SE BNTX	512 M	-	-	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
INmune Bio INMB	47.4 M	$ 1.52	-1.3 %	$ 37.6 M	USA
Exelixis EXEL	598 M	$ 48.7	9.64 %	$ 13.2 B	USA
ACADIA Pharmaceuticals ACAD	708 M	$ 21.48	-3.89 %	$ 3.56 B	USA
Fortress Biotech FBIO	125 M	-	-	$ 71.1 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	343 M	$ 3.15	1.19 %	$ 655 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	-	-	$ 5.51 M	Israel
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 24.17	3.2 %	$ 3.08 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	668 M	$ 55.08	5.15 %	$ 4.95 B	Schweiz
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.7	3.66 %	$ 452 M	Britain
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	249 M	-	-	-	Russia